Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-083026
Filing Date
2025-06-06
Accepted
2025-06-06 16:00:05
Documents
1
Period of Report
2025-06-04

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 4083
  Complete submission text file 0000950170-25-083026.txt   5681
Mailing Address C/O ATYR PHARMA, INC. 10240 SORRENTO VALLEY ROAD, SUITE 300 SAN DIEGO CA 92121
Business Address
Broadfoot Jill Marie (Reporting) CIK: 0001305178 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38327 | Film No.: 251030409

Mailing Address 40 GUEST STREET BOSTON MA 02135
Business Address 40 GUEST STREET BOSTON MA 02135 617-949-2680
Cue Biopharma, Inc. (Issuer) CIK: 0001645460 (see all company filings)

EIN.: 473324577 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)